Use of interventions to minimise perioperative allogeneic blood transfusion in Australia: A survey by the International Study of Perioperative Transfusion (ISPOT) study group

Medical Journal of Australia

Volumn 172, Issue 8, 2000, Pages 365-369

  Henry, David A ^a   Henderson, Kim M ^a   Fryer, Jayne L ^a   Treloar, Carla J ^a   McGrath, Katherine M ^a   Deveridge, Sandra F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; COST EFFECTIVENESS ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; SURGEON; SURGICAL WARD;

EID: 0034678526     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb124007.x     Document Type: Article

References (22)

1. Carson JL, Terrin ML, Barton FB, et al. A pilot randomized trial comparing symptomatic vs hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion 1998; 38: 522-529.
2. Hebert PC, Wells G, Blajchman M, et al. A multi-center, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
3. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. Anesth Analg 1997; 85: 1258-1267.
4. Hospitals and health services year book. 20th ed Melbourne: Peter Isaacson Publications, 1995/96 79-307.
5. Arnold PC. editor. The medical directory of Australia. 21st ed. Sydney: Australasian Medical Publishing Company, 1996; 3-1-3-77.
6. SAS Institute. SAS/STAT users' guide. Version 6. 4th ed. Cary, NC: SAS Institute, 1989.
7. Fergusson D, van Walraven C, Coyle D, Laupacis A. Economic evaluations of technologies to minimize perioperative transfusion: a systematic review of published studies. International Study of Peri-operative transfusion (ISPOT) investigators. Transfus Med Rev 1999; 13: 106-117.
8. Faught C, Wells P, Fergusson D, Laupacis A. Adverse effects of methods for minimizing perioperative allogeneic transfusion. a critical review of the literature. Transfus Med Rev 1998; 12: 206-225.
9. Forgie M, Wells P, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion. The International Study of Perioperative Transfusion (ISPOT) investigators Arch Int Med 1998; 158: 610-616.
10. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion (ISPOT) investigators. Anesth Analg 1998; 86: 9-15.
11. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. The International Study of Perioperatve Transfusion (ISPOT) investigators. Anesth Analg 1999; 89: 861-869.
12. Munoz JJ, Birkmeyer NJO, Birkmeyer JD, et al. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery? a meta-analysis. Circulation 1999; 99: 81-89.
13. Levi M, Cromheecke ME, de Jonge E, et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940-1947.
14. Hebert PC, Schweitzer I, Calder L, et al. Review of the clinical practice literature on allogeneic red blood cell transfusion. CMAJ 1997; 156 (Suppl 11): S9-S26.
15. Whyte GS, Savoia HF. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria. Med J Aust 1997; 166: 584-586.
16. Remis RS, Delage G, Palmer RW. Risk of HIV infection from blood transfusion in Montreal. CMAJ 1997; 157: 375-382.
17. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997; 34: 34-40.
18. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surgery 1998; 85: 171-178.
19. Tretiak R, Laupacis A, Riviere M, et al. Cost of allogeneic and autologous blood transfusion in Canada. CMAJ 1996; 154: 1501-1508.
20. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donation. N Engl J Med 1995; 332: 719-724.
21. Shaheen SP, Lichtiger B. Autologous deposit of blood by oncology patients: an evaluation of actual use and wastage. Ann Surg Oncol 1995; 2: 457-461.
22. Fergusson D, Blair A, Henry D, Hisashige A, et al. Technologies to minimise blood transfusion in cardiac and orthopedic surgery. Results of a practice variation survey in nine countries. Int J Technol Assess Health Care 1999; 15: 717-728.